Figure 9B shows that GC patients’ plasma samples have higher levels of CEBPA-AS1 compared to healthy subjects, which suggests that CEBPA-AS1 is a potential biomarker for the detection of GC [329]. The gene discussed is CEBPA; the disease is gastric cancer.